Survivor, innovator Kim Gandy rewards patients for sticking to treatments
February 24, 2017 | Meghan LeVota
In her 20 years working as a transplantation clinician, Kim Gandy found it baffling that a seemingly simple problem had such a difficult time finding a solution.
Transplant patients consistently struggled to adhere to their health regimens, resulting not only in significant costs for care providers but also death.
“We were literally losing patients,” Gandy said. “In transplant, if you do not adhere to the medications that you need to take after the transplant you can lose the organ — and in heart and lung transplants, that often means you die.”
The problem is not limited to transplant operations — it transcends all chronic conditions.
Gandy said that before the medical field can evolve and introduce new medicines and technology, they need to tackle the basics. Often times it comes down to effective communication.
“A lot of people think there is a lack of adherence because people are lazy or rebellious,” Gandy said. “I’m a glass-half-full type of person, and there is no data to suggest that it’s the case. Truth be told, it is just hard. These regimens are complex and many people don’t understand the necessity.”
It occurred to Gandy that although it’s a well-known problem, nobody was trying to solve it. She said that clinicians seemed to be waiting around for somebody else to do it.
In 2013, Gandy decided to take on the challenge and began her entrepreneurial journey. She founded Play-It Health, a web- and mobile-based platform that makes adherence to prescribed regimens easier to understand and follow. The platform helps effectively communicate a plan, as well as offer rewards for patients that observe their treatment plan.
“Lack of adherence is probably the most actionable problem in the industry,” Gandy said. “Play-It Health has the opportunity to have a stronger impact in health care than anything else I’ve been in contact with.”
Here’s how it works. Patients download the iOS or Android app and then answer a few questions — their favorite color, hobby and others regarding their personal situation. Then, the user will receive push notifications reminding them to adhere to their regimen.
Play-It Health is compatible with over 20 chronic conditions — diabetes, cancer, multiple sclerosis and others — and tracks the user’s adherence to prescribed medications, use of medical devices and appointments with their physician. If the patient fails to adhere, the platform will change its look and feel to re-engage the user. If things get dangerous, Play-It health will connect the user with a telemedicine intervention, connecting them remotely to a clinician on-demand.
When users follow their regimen, they gain points that can be used for retail coupons or through the platform’s game.
“Nothing about this is much different from other rewards platforms that are being used outside of the medical sector,” Gandy said. “They’re just not many rewards platforms being used for this purpose.”
Gandy said that the platform is currently targeting hospital branches and other health institutions to set up pilot programs. The hope is that these institutions will front the cost of the platform, making it free for the patient.
Play-It Health has raised $200,000 to date and is currently raising funds for a $1 million round. Gandy also was a member of Pipeline’s 2016 fellowship class.
Gandy attributes her success to her perspective — both as a clinician and a patient. Shortly after her acceptance to Pipeline, Gandy was diagnosed with breast cancer.
“I’ve been through a lot of phases in my life and been through difficult things,” Gandy said. “But, you just kind of hit bumps in the road and keep going.”
Gandy used Play-It Health herself, which she said gave her fresh eyes on the product.
“It was actually kind of funny,” Gandy said. “I was now looking at using this app as somebody going through chemo as opposed to the clinician prescribing it to somebody going through chemo.”
In addition to the reassurance that the application was helpful to patients, Gandy said the experience gave her new ideas for the platform’s next set of features. After completing her chemo treatment and surgery, Gandy is tumor free and has the odds for survival in her favor. She is optimistic that this experience will help her get Play-It Health in the hands of more people.

2017 Startups to Watch
stats here
Related Posts on Startland News
What comes after the World Cup? Leaders ponder KC’s next phase (and how to get there)
Editor’s note: The following is the first in a four-part series exploring the verticals and impact of initiatives within the Economic Development Corporation of Kansas City through a paid partnership with EDCKC. EDCKC leader: Tapping Kansas City’s full potential requires coordinated eco devo strategy across region Tracey Lewis has lived and worked in some of…
Clock is ticking on World Cup 2026: Small businesses urged to prepare before this buzzer-beater
A massive influx of visitors are expected next year when more than 600,000 fans descend on Kansas City for its piece of the FIFA World Cup 2026 prize, but potential roadblocks lie ahead for small business owners who are waiting for the action instead of preparing now to capitalize on it, said local leaders. “This…
Why KCMO pushed to lock down ‘Kansas City’ brand ahead of its biggest sports event yet
With World Cup visitors already eyeing plane tickets to Kansas City for matches opening in June 2026, clarity around what constitutes “Kansas City” will be key, said Quinton Lucas, who in late 2024 made moves to restrict labeling the city’s name on certain projects. The effort aims to authentically represent KCMO on the world’s stage,…
Downtown KCMO ballpark remains in play as Kansas aggressively pursues Royals
Editor’s note: The perspectives expressed in this commentary are the author’s alone. Gib Kerr is the chair of the Downtown Council of Kansas City, Missouri, managing director at Cushman & Wakefield, and an author. This piece was first published by the Downtown Council. Where should the Royals play baseball? Last year, the debate was whether…
